Revvity | PKI - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.81B 49M 2026-03
Align Technology USD 1.1B 42.76M 2026-06
Bio Techne USD 209.82M 36.94M 2026-03
Bio-Rad Laboratories USD 517M 9.8M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Celltrion KRW 56.79B 6.92B 2026-03
Charles River Laboratories USD 192.02M 195K 2026-06
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Danaher USD 4.35B 1.35B 2026-06
Dentsply International USD 239M 49M 2026-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Edwards Lifesciences USD 2.9B 500M 2026-06
Illumina USD 1.09B 329M 2026-03
Intuitive Surgical USD 8.63B 646.3M 2026-06
IQVIA Holdings USD 1.91B 38M 2026-06
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Laboratory Of America USD 141.8M 839.3M 2026-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Mesa Laboratories USD 28.98M 8.55M 2025-12
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
OraSure Technologies USD 160.58M 16.38M 2026-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pacific Biosciences Of California USD 61M 4.73M 2026-06
Pharma Mar EUR 19.34M 29.53M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
Quest Diagnostics USD 626M 233M 2026-06
Quidel USD 123.4M 17M 2026-06
Repligen USD 606.78M 24.13M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Tilray USD 264.83M 43.16M 2025-06
Waters USD 539M 77M 2026-06
Zealand Pharma A/S 3.85B 727.54M 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03